Memorial Sloan Kettering Cancer Center clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
54 trials changed in the last 30 days: 2 stopped, 39 with notable changes, 13 with minor changes only.
- Stopped: Operator Radiation Exposure During Image-Guided Robotic-Assisted Bronchoscopy: A Multicenter Prospective Cohort Study Trial status changed: Recruiting → Withdrawn
- Notable: Ixazomib Maintenance Study · AL Amyloidosis Primary and study completion pushed from Aug 2026 to Aug 2027
- Notable: Chemotherapy-Induced Hair Changes and Alopecia, Skin Aging and Nail Changes · Non-Metastatic Breast Cancer Primary and study completion pushed from Aug 2026 to Aug 2027
- Minor: In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET Enrollment closed, study ongoing
- Minor: Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer Trial completed
- Notable: Radiation Therapy and Cemiplimab · Skin Cancer Primary and study completion pushed from Oct 6, 2026 to Oct 6, 2027
- Notable: Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options) Primary and study completion dates moved earlier to Jul 31, 2029
- Notable: Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy Primary and study completion pushed from Oct 2026 to Oct 2027
- Notable: Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes · Vulvar Cancer Primary and study completion pushed from Nov 2026 to Nov 2027
- Notable: Neurocognitive Tests and Questionnaires · Head and Neck Cancer Who Are Undergoing Radiation Therapy Enrollment increased: 60 → 185 participants
- Minor: Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients Enrollment closed, study ongoing
- Minor: Iomab-ACT · 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy · Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma Enrollment closed, study ongoing
- Notable: Siltuximab to Decrease Symptom Burden After Autologous Stem Cell Transplantation · Multiple Myeloma and AL Amyloidosis Primary and study completion pushed from Oct 2026 to Oct 2027
- Notable: Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Primary and study completion pushed from Oct 2026 to Oct 2027
- Notable: Proton Versus Photon Beam Radiotherapy · Head and Neck Cancer Primary and study completion pushed from Oct 2026 to Oct 2027
- Notable: Salvage Re-Irradiation of Metastatic Spine Lesions Using Single-Fraction Stereotactic Radiosurgery Primary and study completion pushed from Oct 2026 to Oct 2027
- Notable: Radiation Therapy Before CAR T Cell Therapy · B Cell Lymphoma Primary and study completion pushed from Oct 2026 to Oct 2027
- Notable: Genomic Structural Variation in Cancer Susceptibility Primary and study completion pushed from Oct 2026 to Oct 2027
- Minor: Ruxolitinib and Duvelisib · Lymphoma Enrollment closed, study ongoing
- Notable: Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy Primary and study completion pushed from Oct 2026 to Oct 2027
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-10 | NCT07927998 A Study of Retifanlimab After Chemoradiation in People With Anal Cancer | Phase 2 | Recruiting |
| 2026-11-05 | NCT07918989 A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast… | Phase 2 | Recruiting |
| 2026-11-03 | NCT07913672 A Study of LBP-MARCO and Ruxolitinib in People With Graft-Versus-Host Disease (GVHD) | Phase 1 | Recruiting |
| 2026-10-28 | NCT07899892 A Study of 68Ga-FAPI Breast PET/MRI Scans in People With Breast Cancer | Phase 1 | Recruiting |
| 2026-10-27 | NCT07898111 A Study of VAX-ID® 2200, a New Device for Intradermal Injections | Enrolling by Invitation | |
| 2026-10-26 | NCT07895498 A Study of Standard of Care Drugs With or Without Ivermectin for Daraxonrasib-Induced… | Phase 2 | Recruiting |
| 2026-10-26 | NCT07895511 A Study of Skipping Radiation Therapy in People With Breast Cancer | Recruiting | |
| 2026-10-22 | NCT07890415 Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis | Phase 3 | Recruiting |
| 2026-10-21 | NCT07886801 A Study of Ropeg-Interferon in People With Polycythemia Vera | Phase 2 | Recruiting |
Active trials by phase
| Early Phase 1 | 20 | |
| Phase 1 | 93 | |
| Phase 1/2 | 39 | |
| Phase 2 | 236 | |
| Phase 2/3 | 1 | |
| Phase 3 | 23 | |
| Phase 4 | 6 |
Not charted: 289 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 48
Breast Cancer (107) · Lung Cancer (49) · Leukemia (46) · Head & Neck Cancer (41) · Prostate Cancer (41) · Non-Hodgkin Lymphoma (40) · Sarcoma (39) · Multiple Myeloma (35) · Colorectal Cancer (32) · Pancreatic Cancer (24)
Get alerts when Memorial Sloan Kettering Cancer Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.